Dr. Joshua Amit Budhu, MD

Dr. Budhu practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Budhu's NPI, 1508229691, was assigned on April 5, 2016. Dr. Budhu graduated from Morehouse School Of Medicine in 2016. Dr. Budhu holds New York license 315626.

Dr. Budhu's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Budhu's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Budhu to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Budhu practices. Vendor and product names are available with a free account.

Neurology is Dr. Budhu's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Budhu is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Budhu's licenses on file in 5 states: New York, Florida, New Jersey, Connecticut and Massachusetts.

Dmand AI lists cerebrovascular disease, hereditary polyneuropathy, neuropathy, seizures and stroke among the conditions Dr. Budhu treats.

CMS data shows 289 Medicare services from Dr. Budhu across 7 procedure codes in 2024, for 173 Medicare patients. Medicare paid $29,945 for them.

CMS counts 173 Medicare patients who saw Dr. Budhu in 2024. The largest group is 65 to 74, with 71 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 3.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Budhu's median patient age at 67, with 57% women.

In 2024, Dr. Budhu wrote 290 Medicare Part D claims for 72 patients. 79% of them were for generic drugs. CMS names the drug for 166 of them, across 9 drugs with 11 or more claims each, at $160,759 in total drug cost. In 2023, CMS named 208 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Budhu for performance year 2024, reported as part of a group. Dr. Budhu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Budhu as offering telehealth.

Dmand AI links 19 papers to Dr. Budhu, published from 2020 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Brain Neoplasms, Internship and Residency and Medical Oncology. Dr. Budhu has published most often in Neurology. Dr. Budhu's most frequent co-authors are Ugonma Nnenna Chukwueke, MD, Susan M. Chang, MD and Patrick Yung Wen, MD.

Dr. Budhu graduated from Morehouse School Of Medicine in 2016. Dr. Budhu is a member of AAN.

Dr. Budhu is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.